rs373862340
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_019098.5(CNGB3):c.1006G>T(p.Glu336Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,583,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_019098.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNGB3 | NM_019098.5 | c.1006G>T | p.Glu336Ter | stop_gained | 9/18 | ENST00000320005.6 | NP_061971.3 | |
CNGB3 | XM_011517138.3 | c.592G>T | p.Glu198Ter | stop_gained | 7/16 | XP_011515440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGB3 | ENST00000320005.6 | c.1006G>T | p.Glu336Ter | stop_gained | 9/18 | 1 | NM_019098.5 | ENSP00000316605 | P1 | |
CNGB3 | ENST00000681546.1 | n.826G>T | non_coding_transcript_exon_variant | 4/13 | ||||||
CNGB3 | ENST00000681746.1 | c.1006G>T | p.Glu336Ter | stop_gained, NMD_transcript_variant | 9/19 | ENSP00000505959 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150506Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000371 AC: 9AN: 242268Hom.: 0 AF XY: 0.0000456 AC XY: 6AN XY: 131492
GnomAD4 exome AF: 0.0000342 AC: 49AN: 1433010Hom.: 0 Cov.: 29 AF XY: 0.0000365 AC XY: 26AN XY: 712864
GnomAD4 genome AF: 0.0000266 AC: 4AN: 150506Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73448
ClinVar
Submissions by phenotype
Achromatopsia 3 Pathogenic:4
Pathogenic, no assertion criteria provided | research | Molecular Genetics Laboratory, Institute for Ophthalmic Research | Mar 27, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 07, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Sep 17, 2014 | - - |
Pathogenic, no assertion criteria provided | research | Laboratory of Genetics in Ophthalmology, Institut Imagine | - | - - |
Achromatopsia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota | Oct 03, 2018 | - - |
Pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change creates a premature translational stop signal (p.Glu336*) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is present in population databases (rs373862340, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with achromatopsia (PMID: 15657609, 24148654, 27479814, 28795510). ClinVar contains an entry for this variant (Variation ID: 188968). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jun 29, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at